Primary completion date for Phase 1 and 2 is: May 2026.
suffice to say there are multiple share price inflection points between and then and if the toxicity and efficacy results are anywhere near the pre clinical data, this company will get taken over…we should have prelim data in a few months so watch this space….
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial, page-24
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $9.751M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $41.55K | 4.610M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1934891 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 2853536 | 6 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |